Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oncothyreon buys Alpine Biosciences for $26.2mm in stock

Executive Summary

Cancer therapeutics developer Oncothyreon Inc. issued 9.3mm of its common shares (valued at $26.2mm based on the market average) to acquire Alpine Biosciences Inc., a privately held company utilizing a nanotechnology platform to develop targeted treatments for cancer and rare diseases.
Deal Industry
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Stock
    • Includes Contract

Related Companies